Abstract
Patients who had an increase in their serum amyloid type A level of >100% in the first 24 hours after percutaneous transluminal coronary angioplasty (PTCA) and also developed a positive antibody result (antinuclear factor or anticardiolipin), had a relative risk of 10.6 for developing restenosis in the first year after PTCA.
Original language | English |
---|---|
Pages (from-to) | 339-341 |
Number of pages | 3 |
Journal | American Journal of Cardiology |
Volume | 81 |
Issue number | 3 |
DOIs | |
State | Published - 1 Feb 1998 |
Externally published | Yes |